Literature DB >> 24829464

Impaired colonic B-cell responses by gastrointestinal Bacillus anthracis infection.

Bikash Sahay1, Jennifer L Owen2, Mojgan Zadeh1, Tao Yang1, Yaíma L Lightfoot1, Firas Abed1, Mansour Mohamadzadeh1.   

Abstract

Ingestion of Bacillus anthracis spores causes gastrointestinal (GI) anthrax. Humoral immune responses, particularly immunoglobulin A (IgA)-secreting B-1 cells, play a critical role in the clearance of GI pathogens. Here, we investigated whether B. anthracis impacts the function of colonic B-1 cells to establish active infection. GI anthrax led to significant inhibition of immunoglobulins (eg, IgA) and increased expression of program death 1 on B-1 cells. Furthermore, infection also diminished type 2 innate lymphoid cells (ILC2) and their ability to enhance differentiation and immunoglobulin production by secreting interleukin 5 (IL-5). Such B-1-cell and ILC2 dysfunction is potentially due to cleavage of p38 and Erk1/2 mitogen-activated protein kinases in these cells. Conversely, mice that survived infection generated neutralizing antibodies via the formation of robust germinal center B cells in Peyer's patches and had restored B-1-cell and ILC2 function. These data may provide additional insight for designing efficacious vaccines and therapeutics against this deadly pathogen.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B-1 cells; Bacillus anthracis; anthrax toxin; type 2 innate lymphoid cells

Mesh:

Year:  2014        PMID: 24829464      PMCID: PMC4271052          DOI: 10.1093/infdis/jiu280

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria.

Authors:  A J Macpherson; D Gatto; E Sainsbury; G R Harriman; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  2000-06-23       Impact factor: 47.728

2.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 3.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 4.  Pathogen subversion of cell-intrinsic innate immunity.

Authors:  Craig R Roy; Edward S Mocarski
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

5.  Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.

Authors:  S P Spencer; C Wilhelm; Q Yang; J A Hall; N Bouladoux; A Boyd; T B Nutman; J F Urban; J Wang; T R Ramalingam; A Bhandoola; T A Wynn; Y Belkaid
Journal:  Science       Date:  2014-01-24       Impact factor: 47.728

6.  Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites.

Authors:  Y Wang; R Prywes
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

7.  Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.

Authors:  Sou-Ichi Makino; Masahisa Watarai; Hyeng-Il Cheun; Toshikazu Shirahata; Ikuo Uchida
Journal:  J Infect Dis       Date:  2002-06-27       Impact factor: 5.226

8.  Bacillus subtilis isolated from the human gastrointestinal tract.

Authors:  Huynh A Hong; Reena Khaneja; Nguyen M K Tam; Alessia Cazzato; Sisareuth Tan; Maria Urdaci; Alain Brisson; Antonio Gasbarrini; Ian Barnes; Simon M Cutting
Journal:  Res Microbiol       Date:  2008-11-28       Impact factor: 3.992

9.  Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.

Authors:  Charlly Kao; Kenneth J Oestreich; Michael A Paley; Alison Crawford; Jill M Angelosanto; Mohammed-Alkhatim A Ali; Andrew M Intlekofer; Jeremy M Boss; Steven L Reiner; Amy S Weinmann; E John Wherry
Journal:  Nat Immunol       Date:  2011-05-29       Impact factor: 25.606

10.  Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.

Authors:  Haijing Hu; Stephen H Leppla
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more
  6 in total

Review 1.  New insights into gastrointestinal anthrax infection.

Authors:  Jennifer L Owen; Tao Yang; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2014-12-19       Impact factor: 11.951

Review 2.  Group 2 innate lymphoid cells in disease.

Authors:  Timotheus Y F Halim
Journal:  Int Immunol       Date:  2015-08-25       Impact factor: 4.823

3.  Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis.

Authors:  Karen E Kempsell; Stephen P Kidd; Kuiama Lewandowski; Michael J Elmore; Sue Charlton; Annemarie Yeates; Hannah Cuthbertson; Bassam Hallis; Daniel M Altmann; Mitch Rogers; Pierre Wattiau; Rebecca J Ingram; Tim Brooks; Richard Vipond
Journal:  Front Microbiol       Date:  2015-08-13       Impact factor: 5.640

Review 4.  Crossing of the epithelial barriers by Bacillus anthracis: the Known and the Unknown.

Authors:  Pierre L Goossens; Jean-Nicolas Tournier
Journal:  Front Microbiol       Date:  2015-10-09       Impact factor: 5.640

5.  Impact of Gastrointestinal Bacillus anthracis Infection on Hepatic B Cells.

Authors:  Natacha Colliou; Bikash Sahay; Mojgan Zadeh; Jennifer L Owen; Mansour Mohamadzadeh
Journal:  Toxins (Basel)       Date:  2015-09-22       Impact factor: 4.546

6.  Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling.

Authors:  Sudarshan Seshadri; David S J Allan; James R Carlyle; Lauren A Zenewicz
Journal:  PLoS Pathog       Date:  2017-10-23       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.